Diane Gosselin appointed President and Chief Executive Officer of CQDM

CQDM and Epitopea Fund the Development and Validation of CryptoMapTM a Supportive Platform Enabling the Development of RNA-based Immunotherapies

CQDM 26/09/2024

GlycoNet and CQDM collaborate to boost drug discovery and develop new health solutions for Canadians

CQDM 19/09/2024

4th edition of Sweet Biopharma Day – Call for entries now open

CQDM 3/09/2024